Cargando…
5-ASA-loaded SiO(2) nanoparticles-a novel drug delivery system targeting therapy on ulcerative colitis in mice
The targeting of 5-aminosalicylic acid (5-ASA), a first-line therapeutic agent for mild to moderate active ulcerative colitis (UC), to the site of inflammation has remained a challenge and an unmet requirement in the treatment of UC. However, nanoscale carriers for targeted drug delivery are promisi...
Autores principales: | Tang, Haiying, Xiang, Dan, Wang, Feng, Mao, Jingwei, Tan, Xiaoyan, Wang, Yingde |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367343/ https://www.ncbi.nlm.nih.gov/pubmed/28138699 http://dx.doi.org/10.3892/mmr.2017.6153 |
Ejemplares similares
-
Efficacy and safety of adsorptive granulomonocytapheresis in Chinese patients with ulcerative colitis: A retrospective analysis of 50 cases with focus on factors impacting clinical efficacy
por: Li, Na, et al.
Publicado: (2020) -
Optimizing use of 5-ASA in the treatment of ulcerative colitis: Focus on patient compliance and adherence
por: Bernick, Steven J, et al.
Publicado: (2010) -
Modelling the benefits of an optimised treatment strategy for 5-ASA in mild-to-moderate ulcerative colitis
por: Louis, Edouard, et al.
Publicado: (2022) -
SiO-induced thermal instability and interplay between graphite and SiO in graphite/SiO composite anode
por: Lee, Ban Seok, et al.
Publicado: (2023) -
Diffusion doping route to plasmonic Si/SiO(x) nanoparticles
por: Bubenov, Sergei S., et al.
Publicado: (2018)